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Background: CLEC-2 signals through a cytosolic YXXL downstream of a triacidic amino acid sequence (hemITAM).
Results:We show a critical role for the triacidic amino acid in phosphorylation of the cytosolic tyrosine and that CLEC-2 signals
via Syk but not Zap-70.
Conclusion: CLEC-2 signaling requires a cytosolic triacidic amino acid sequence and Syk.
Significance: Proximal signaling events by hemITAM receptors are distinct to those in ITAM receptors.
CLEC-2 is a member of new family of C-type lectin receptors
characterized by a cytosolic YXXL downstream of three acidic
amino acids in a sequence known as a hemITAM (hemi-immu-
noreceptor tyrosine-based activation motif). Dimerization of
two phosphorylated CLEC-2 molecules leads to recruitment of
the tyrosine kinase Syk via its tandem SH2 domains and initia-
tion of a downstream signaling cascade. Using Syk-deficient and
Zap-70-deficient cell lines we show that hemITAM signaling is
restricted to Syk and that the upstream triacidic amino acid
sequence is required for signaling. Using surface plasmon reso-
nance andphosphorylation studies, we demonstrate that the tri-
acidic amino acids are required for phosphorylation of the
YXXL.These results further emphasize the distinct nature of the
proximal events in signaling by hemITAM relative to ITAM
receptors.
The C-type lectin receptor CLEC-24 is highly expressed on
platelets and at lower levels on subpopulations of hematopoi-
etic cells, including mouse neutrophils (1–3). Platelet CLEC-2
is required for the separation of the vascular and lymphatic
systems during development (4–6). The only known endoge-
nous ligand for CLEC-2 is podoplanin, which is expressed at
high levels in several cell types including lymphatic endothelial
cells, kidney podocytes, choroid plexus, and type I lung alveolar
cells. Podoplanin-deficient mice also have defects in the sepa-
ration of the vascular and lymphatic systems that phenocopy
those in the CLEC-2-deficient mice (7, 8).
CLEC-2 signals through a cytosolic YXXL sequence which is
downstream of three acidic amino acids in a motif known as a
hemITAM (9). Signaling takes place in lipid rafts and is medi-
ated through activation of Src and Syk tyrosine kinases and
phosphorylation of key adapter proteins and PLC isoforms (9,
10). The CLEC-2 signaling pathway is similar to that of ITAM
receptors which have two YXXLs separated by 6–12 amino
acids andwhich includeGPVI, the platelet collagen receptor, in
complexwith the FcR-chain (2, 3, 9–11). The proximal events
in signaling by hemITAM and ITAM receptors are thought to
be distinct; phosphorylation of the CLEC-2 hemITAM is
dependent on Syk tyrosine kinase whereas phosphorylation of
ITAM receptors is mediated by Src family tyrosine kinases (12,
13). Strikingly, mice deficient in Syk, the adapter SLP-76 and
PLC2, have defects in the separation of the lymphatic and
blood vasculatures, demonstrating a requirement for platelet
activation downstream of podoplanin and CLEC-2 in this
developmental process (6, 14–16).
CLEC-2 (2) and Dectin-1 (17) were the first two members to
be identified of the hemITAM family of C-type lectin receptors
which are characterized by a triacidic amino acid sequence
upstream of a YXXL (Fig. 1). Both receptors, and the third
hemITAM receptor to be identified, CLEC9A (18), have three
acidic amino acids preceding the YXXL at the2,3, and4
positions. A further three C-type lectins found in NK cells were
recently identified among which NKp80 also adheres to the
consensus sequence (19). In contrast, NKp65 andNKR-P1A are
increasingly divergent in terms of the conserved triacidic amino
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and A. P. are employees of Portola Pharmaceuticals.
Author’s Choice—Final version full access.
□S This article contains Supplemental Table 1.
1 To whom correspondence should be addressed. Tel.: 44-0-121-415-8678;
E-mail: c.e.hughes@bham.ac.uk.
2 Received research support from the National Institute for Health Research
Oxford Comprehensive Biomedical Research Centre Program.
3 Holds British Heart Foundation Chair CH/03/003.
4 The abbreviations used are: CLEC-2, C-type lectin receptor-2; hemITAM,
hemi-immunoreceptor tyrosine-based activationmotif; NFAT, nuclear fac-
tor of activated T-cells; NK, natural killer; PLC, phospholipase C; SH2, Src
homology 2.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 288, NO. 7, pp. 5127–5135, February 15, 2013
Author’s Choice © 2013 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
FEBRUARY 15, 2013•VOLUME 288•NUMBER 7 JOURNAL OF BIOLOGICAL CHEMISTRY 5127
 at The U
niversity of Birm
ingham
 on M
arch 3, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
acids but retain theYXXL. It is not yet knownwhether theseNK
C-type lectin receptors also signal through Syk (19).
CLEC-2 and CLEC9A are expressed as dimers on the cell
surface. It is proposed that ligand engagement leads to further
clustering with the tandem SH2 domains of Syk bridging two
phosphorylated hemITAMs in two separate dimer combina-
tions (3, 18, 20). Subsequently, a combination of Src kinase
phosphorylation and autophosphorylation leads to further acti-
vation of Syk and initiation of a signaling pathway culminating
in phospholipase C2 (PLC2) activation (2, 3, 9–11).
To date, the publications on this novel family of receptors
have described a dependence on Syk for signaling (18, 19, 21)
but have not investigated the dependence on the othermember
of the Syk family of tyrosine kinases, Zap-70. Both kinases pos-
sess tandem SH2 domains required for ITAM signaling, but
they differ in many ways including a much lower intrinsic
kinase activity and conformational restraints in Zap-70 which
may preclude the bridgingmodel described above.On the other
hand, there are several reports of signaling by CLEC-2 in trans-
fected Jurkat T cells which express Zap-70 at high levels, but
little or no Syk (2, 9, 21).
In this study we have investigated the role of the triacidic
amino acid sequence and the ability of Zap-70 to mediate sig-
naling by CLEC-2. We show that the triacidic amino acid
sequence is critical for hemITAM phosphorylation but that
CLEC-2 is unable to signal via Zap-70.
EXPERIMENTAL PROCEDURES
Reagents—Rhodocytin was purified from Calloselasma rho-
dostoma venom (22). A rabbit -Syk polyclonal antibody (pAb)
was used as reported (23). The goat -human CLEC-2 pAb was
purchased from R&D Systems. The -Myc monoclonal anti-
body (mAb) 9B11 was from Cell Signaling Technology. The
mouse -FcRIIA mAb (IV.3) was kindly provided by Dr. Y.
Senis. Horseradish peroxidase-conjugated -rabbit and
-goat secondary antibody and enhanced chemilumines-
cence reagents were purchased from Amersham Biosciences.
GST fusion proteins corresponding to single or tandem SH2
domains of Syk were prepared as described previously (24, 25).
Biotinylated peptides were synthesized by Severn Biotech. All
other reagents were purchased from Sigma-Aldrich or from
described sources (26).
Platelet Preparation—Venous blood from healthy drug-free
volunteers was taken into 10% sodium citrate.Washed platelets
were obtained by centrifugation using prostacyclin to prevent
activation during the isolation procedure (3). Platelets were
resuspended in modified Tyrode’s buffer (134 mM NaCl, 0.34
mM Na2HPO4, 2.9 mM KCl, 12 mM NaHCO3, 20 mM HEPES, 5
mM glucose, 1 mM MgCl2; pH 7.3) as described (3). Platelets
were used at a cell density of 5 108/ml unless stated otherwise.
Immunoprecipitation, Pulldowns, and Western Blotting—
Washedplateletswere pretreatedwith 9M Integrilin to inhibit
platelet aggregation through integrinIIb3. Stimulationswith
collagen-related peptide (CRP) or mAb IV.3 were pretreated
with 10 M indomethacin and 2 units/ml apyrase to inhibit
thromboxane production and block ADP, respectively. Plate-
lets were stimulated with agonists at 37 °C with stirring at 1200
rpm in a Born lumiaggregometer. Reactions were terminated
by addition of 2 ice-cold Nonidet P-40 lysis buffer. Platelet
lysateswere precleared, and detergent-insoluble debris was dis-
carded. An aliquot was dissolved with SDS sample buffer for
detection of total tyrosine phosphorylation. Lysates were incu-
bated with either the indicated antibodies and protein G- or
protein A-Sepharose. Precipitated proteins and whole cell
lysates were separated by reducing SDS-PAGE, electrotrans-
ferred, and Western blotted.
Constructs—Wild type CLEC-2 cloned into pEF6 has been
described (9, 27). Further mutations were generated by PCR
using the mutating primers CLEC-2 2–5 (5-TAG-GGA-
TCC-ACC-ATG-GGA-TAC-ATC-ACC-TTA-AAT-ATT-
AAA-ACT-CGG-3), CLEC-2 2–5 Ala (5-TAG-GGA-TCC-
ACC-ATG-GCG-GCT-GCA-GCT-GGA-TAC-ATC-ACC-
TTA-AAT-ATT-AAA-ACT-CGG-3), CLEC-2 2–5 Arg (5-
TAG-GGA-TCC-ACC-ATG-CGG-CGT-CGA-CGT-GGA-
TAC-ATC-ACC-TTA-AAT-ATT-AAA-ACT-CGG-3),
CLEC-2 3–5 Ala (5-TAG-GGA-TCC-ACC-ATG-CAG-GC-
T-GCA-GCT-GGA-TAC-ATC-ACC-TTA-AAT-ATT-AAA-
ACT-CGG-3) along with vector specific primer 4150. CLEC-
2/FcR chimeras were generated by a two-step PCR method
using WT CLEC-2 and the previously described FcR point
mutants as templates (3). Themutating primersCLEC-2/FcR
FWD (5-GAA-GCA-TGA-GAA-ACC-ACC-ACA-GTG-
GTG-GCG-TGT-GAT-GGC-TTT-G-3), CLEC-2/FcR REV
(5-CAA-AGC-CAT-CAC-ACG-CCA-CCA-CTG-TGG-TGG-
TTT-CTC-ATG-CTT-C-3), FcR YXXL (5-TAG-GGA-
TCC-ACC-ATG-AAA-TCA-GAT-GGT-GTT-TAC-ACG-
GGC-3), and FcR FXXL (5-TAG-GGA-TCC-ACC-ATG-
AAA-TCA-GAT-GGT-GTT-TTC-ACG-GGC-3) were used
alongwith vector-specific primer 4150, and furthermutation of
the chimera was generated by PCR using the mutating primer
CLEC-2/FcR DED YXXL (5-TAG-GGA-TCC-ACC-ATG-
CAG-GAT-GAA-GAT-GGA-TAC-ACG-GGC-CTG-AGC-
ACC-AGG-3) with vector-specific primer 4150. The nuclear
FIGURE 1. Sequence alignment of hemITAM receptors. The intracellular tails of CLEC-2, Dectin-1, CLEC9A, NKp80, NKp65, and NKR-P1A were aligned using
ClustalW software. The conserved YXXL and upstream acidic amino acids are indicated in bold and underlined.
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factor of activated T-cells (NFAT) luciferase reporter contains
three copies of the distalNFAT site from the IL-2 promoter (28)
and was provided by Prof. A. Weiss.
Cell Culture and Transfection—DT40 chicken B cells were
grown in RPMI 1640 medium supplemented with 10% fetal
bovine serum, 1% chicken serum, 100 units/ml penicillin, 100
g/ml streptomycin, 50 M -mercaptoethanol, and 20 mM
GlutaMAX. Cells were transfected in 400 l of Cytomix by
electroporation using a GenePulser II (Bio-Rad) set at 350 V
and 500 microfarads.
Luciferase Assay—Cells were transfected as described above
with 10 g of the indicatedMyc-tagged CLEC-2 constructs, 15
g of the luciferase reporter construct (9, 27), andwhere stated,
5 g of Myc-tagged Syk or Myc-tagged Zap-70. Twenty hours
after transfection, live cells were counted by trypan blue exclu-
sion and samples divided for luciferase assay (1 105/well) and
flow cytometry (5 105). Luciferase assays were carried out as
described previously (29). Luciferase activity was measured
with a Centro LB 960microplate luminometer (Berthold Tech-
nologies). All luciferase data were averaged from triplicate
readings.
Flow Cytometry—Surface expression of Myc-tagged CLEC-2
wasmeasured by flow cytometry. Cells (5 105)were stained in
a 25l volume for 20min on icewith 10g/ml-Myc antibody.
Cells were thenwashed and incubated for 20min on ice with 15
g/ml FITC-conjugated -mouse IgG secondary antibody.
Stained cells were analyzed using a FACSCalibur (BD Biosci-
ences). Data were collected and analyzed using Cellquest soft-
ware (BD Biosciences).
Surface Plasmon Resonance—Surface plasmon resonance
experiments were performed using a Biacore T100 machine
(Biacore, GEHealthcare). Biotin-tagged CLEC-2 peptides were
attached to carboxymethylated dextran-coated CM5 research
grade sensor chips (Biacore) following attachment of streptavi-
din to the chip surface using amine coupling. All experiments
were performed at 25 °C in 10 mM HEPES, pH 7.4, 150 mM
NaCl, 1 mM MgCl2, 0.005% (v/v) polysorbate 20. GST-tagged
recombinant Syk domains were expressed and purified as
described previously (3). The domains expressed were the
N-terminal SH2 domain (N-SH2), the C-terminal SH2 domain
(C-SH2), and both SH2domainswith the linker region, referred
to as the tandem SH2 domains (tSH2). A range of concentra-
tions (0–250 M) of N-SH2, C-SH2, and tSH2 domains were
injected over all peptide surfaces to determine equilibrium dis-
sociation constants (KD). Specific binding was identified by
subtraction of the signal from an appropriate reference flow
cell. KD values were derived by nonlinear fitting using the Lev-
enberg-Marquardt algorithm as implemented in the program
Origin (OriginLab).
Statistical Analysis—NFAT-luciferase data are expressed as
means S.E. Statistical analysis was carried out using unpaired
Student’s t test. Significance was taken for p 0.05.
RESULTS
HemITAM Signaling Is mediated by Syk but Not Zap-70—
Zap-70 and Syk are the only twomembers of a family of tyrosine
kinases characterized by the presence of tandem SH2 domains
and shown to mediate signaling by ITAM receptors. To date,
there has been no comparison of the ability of Zap-70 and Syk
to mediate signaling by hemITAM receptors. To address this,
Syk/ DT40 cells were transiently transfected with CLEC-2
and either Syk or Zap-70, and activation wasmonitored using a
highly sensitive NFAT reporter assay. Transfection of CLEC-2
alone was insufficient to reconstitute signaling to the snake
venom ligand, rhodocytin (Fig. 2A). Signaling in response to
rhodocytin was restored upon co-transfection of CLEC-2 with
Syk but not with Zap-70 despite similar levels of expression as
shown by Western blotting for a Myc tag which was present at
the C terminus of both kinases (Fig. 2A). Importantly, tagging
with Myc at this position does not interfere with activation of
Zap-70 by ITAM receptors (30). To confirm this observation,
we expressed Syk and Zap-70 in a Zap-70-deficient Jurkat cell
line (P116) that had been generated by chemical mutagenesis.
This cell line also lacks Syk as shownbyWestern blotting and its
failure to support signaling through the T-cell receptor (30, 31).
CLEC-2 signaling could only be detected in cells co-transfected
with both CLEC-2 and Syk, but not with CLEC-2 and Zap-70
(Fig. 2B). It is noteworthy that the level of signaling in these cells
is low, whichmay reflect the presence of other uncharacterized
mutations produced by the chemical mutagenesis strategy.
Together these data demonstrate that hemITAM signaling
can be mediated by Syk but not Zap-70. However, we have
previously reconstituted signaling by CLEC-2 in a Jurkat T cell
line which is contrary to the present findings (9). One explana-
tion for this would be the residual presence of a low level of Syk
in the Jurkat T cell line used in the original study. To investigate
this possibility, we expressed CLEC-2 in the same Jurkat cell
line and confirmed activation of the NFAT reporter (Fig. 2C).
Strikingly, however, this signal was completely inhibited in the
presence of a low concentration of the highly selectively Syk
inhibitor, PRT318 (0.5 M) (32). At this concentration, PRT318
inhibits Syk by 99% but shows only weak inhibition of Zap-70
(32).Thisdemonstrates that theprevious reportofCLEC-2 signal-
ing in the Jurkat cell line was mediated by endogenous Syk.
A Differential Role for Syk in HemITAM versus ITAM
Signaling—A previous study using the Syk inhibitor R406 (12)
revealed an unexpected role for Syk in mediating phosphoryla-
tion of the hemITAM receptor in human platelets. Because of
concerns over the selectivity of R406 toward Syk relative to Src
kinases, we have extended these studies to the highly selective
Syk inhibitor, PRT318. As shown in Fig. 3, a low concentration
of PRT318 (0.25 M) inhibited phosphorylation of PLC2 in
platelets by the two ITAM receptors, GPVI and FcRIIA, and
also by the hemITAM receptor CLEC-2. Phosphorylation of
PLC2 is fully inhibited in the presence of a high concentration
of PRT318 (2.5 M) which is consistent with Syk activity mod-
ulating downstream phosphorylation events. In the case of the
ITAM receptors, phosphorylation of Syk and the two receptor
ITAMs, FcR and FcRIIA, is not affected by PRT318 but is
completely blocked by the Src kinase inhibitor PP2, consistent
with a model in which Src family kinases phosphorylate both
the ITAM and Syk. In the case of CLEC-2, however, PRT318
completely blocks CLEC-2 phosphorylation and partially
blocks Syk phosphorylation, both of which are also completely
blocked by PP2. The observation of partial Syk phosphorylation
despite the complete abolition of CLEC-2 phosphorylation is
CLEC-2 Signaling Requires Syk and the HemITAM
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FIGURE 2. CLEC-2 signaling ismediated by Syk and not Zap-70. Syk/DT40 cells (A) or Zap-70 Jurkat cells (B) or WT Jurkat cells (C) were transfectedwith
CLEC-2 and the NFAT-luciferase reporter gene, and where indicated, with Syk or Zap-70. Transfected cells were stimulated with 50 nM rhodocytin, and where
indicated, with the addition of 0.5 M PRT318, for 6 h at 37 °C, after which time luciferase activity was measured as a readout of signaling. Results were
normalized to -fold increases over the basal response. Error bars represent themeans S.E. of at least three separate experiments. Cell lysates were analyzed
by SDS-PAGE andWestern blotting (WB) for Myc to demonstrate similar levels of Syk and Zap-70 expression (insets). Equal loading was confirmed byWestern
blotting for actin.
FIGURE 3. Differential role for Syk in mediating ITAM and hemITAM phosphorylation. Washed platelets (5  108/ml) were stimulated with collagen-
related peptide (CRP; 3 g/ml; 90 s), IV.3 antibody (2 g/ml; 120 s) ( secondary cross-linker (sheep -mouse F(ab)2; 30 g/ml; 300 s)) or rhodocytin (300 nM;
180 s) in thepresenceof PRT318 (0.25Mor 2.5M)or PP2 (10M) and subsequently lysed. Proteinswere immunoprecipitated (IP)with specific pAbs for PLC2,
Syk, and CLEC-2 and then separated by SDS-PAGE and Western blotted for phosphotyrosine. Membranes were then reprobed with the immunoprecipitated
antibodies to measure equal loading. Images are representative of two separate experiments.
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consistent with amodel in which Src kinase-mediated Syk acti-
vation precedes an initial round of phosphorylation of the
hemITAM receptor. This is followed by further phosphoryla-
tion of Syk as a consequence of binding to the phosphorylated
hemITAM, a proportion of which may be mediated by auto-
phosphorylation. This adds to the growing evidence for a key
mechanistic difference between the proximal events in the
GPVI and CLEC-2 signaling cascades and extends this obser-
vation to a second platelet ITAM receptor, FcRIIA.
The Triacidic Amino Acid Sequence Is Required for Activa-
tion of Syk by CLEC-2—It has previously been shown that the
three acidic amino acids upstreamof the YXXL inDectin-1 play
a role in phagocytosis (21). The equivalent sequence in CLEC-2
has been studied in part by single point mutations with incon-
clusive results (9). We therefore extended this work using two
approaches. First, deletion of the triacidic amino acid region
and upstream glutamine residue and second, replacement of all
four residues with either uncharged alanine or basic arginine
residues (Fig. 4). We chose to mutate all four residues because
the triacidic amino acid sequence is spread over these four res-
idues in the hemITAM receptor, NKp65. The rationale for the
argininemutantwas to investigatewhether the requirement for
the acidic amino acid region is simply to provide an opposing
charge that helps to separate the cytoplasmic tails in the
CLEC-2 dimer. All three mutations resulted in a complete
abrogation of CLEC-2 signaling in transfected DT40 cells in
response to rhodocytin even though there was still surface
expression of the mutants (see Supplemental Table 1).
We designed short, biotinylated, tyrosine-phosphorylated
peptides to mimic the hemITAM and surrounding residues of
wild type CLEC-2 and the deletion and alanine substitution
mutants described above.We have shown previously that asso-
ciation between CLEC-2 and Syk does not occur in the absence
of phosphorylation of the hemITAM (3). The interaction of Syk
with these mutant hemITAM sequences was analyzed by sur-
face plasmon resonance. The peptides were immobilized on
streptavidin-coated sensor chips, and recombinant proteins of
the Syk N-terminal SH2 domain (N-SH2), C-terminal SH2
domain (C-SH2) or tandem SH2 domains (tSH2) were flowed
over. None of the recombinant proteins exhibited detectable
binding to the2–5 peptide (Fig. 5). On the other hand, the Syk
N-SH2 domain had a similar affinity for wild type and the ala-
nine mutant peptides, whereas there was a 4-fold decrease in
the affinity of the alanine mutant peptide for the C-SH2
domain, which presumably accounts for the 3-fold decrease in
affinity for the tSH2 domains (Fig. 5). Thus, these results dem-
onstrate that the mutation of the upstream triacidic amino
acids has only aminor effect on the binding of Syk to phosphor-
ylated peptides based on the CLEC-2 cytoplasmic tail and that
they are therefore not essential for the interaction.
The DED Sequence Is Required for HemITAM Phos-
phorylation—Based on the above results, we made a further
alanine CLEC-2 mutant to confirm that it was solely the nega-
tively charged DED sequence that was required for CLEC-2
signaling and tested it in the NFAT reporter assay. This addi-
tional mutant (3–5 Ala) was also unable to signal (Fig. 6). To
investigate the possibility that the abrogation of signaling was
mediated by loss of phosphorylation of the mutant CLEC-2, we
stimulated transfected DT40 cells with rhodocytin and measured
phosphorylation following immunoprecipitation. Rhodocytin
stimulated tyrosine phosphorylation of wild type CLEC-2 but
induced no significant phosphorylation of the 3–5 Ala mutant.
Therefore, the loss of activity in the NFAT assay is explained by
loss of phosphorylation of the mutant CLEC-2.
The HemITAM DED Can Confer Signaling to a Mutant
ITAM—We have reported previously that signaling by the
GPVI/FcR ITAM receptor is either ablated or inhibited by
95% following mutation of either of the conserved ITAM
tyrosines thereby demonstrating that it is unable to signal in the
same way as a hemITAM receptor (3). To ascertain whether
this result is because of the requirement for the triacidic amino
acid sequence upstream of the YXXL, we engineered a CLEC-2
chimera expressing the extracellular and transmembrane
domains of CLEC-2 with some intracellular sequence sur-
rounding the FcR ITAM. Rhodocytin stimulated a marked
increase in NFAT activity in a chimera expressing the wild type
FcR ITAM(Fig. 7). In contrast, pointmutations of either of the
ITAM tyrosines completely inhibited the response to rhodocy-
tin (Fig. 7) even though both mutants were expressed at a level
similar to the wild type receptor (see Supplemental Table 1).
We then investigated whether the placement of the triacidic
amino acid sequence fromCLEC-2 upstream of theN-terminal
YXXL sequence was able to restore signaling to rhodocytin in
the CLEC-2/FcR chimera. Strikingly, rhodocytin was able to
induce an increase in NFAT activity in the DED-Y2F chimera
similar to that seen in wild type CLEC-2, demonstrating that
the DED sequence was sufficient to convert activation by the
hybrid receptor.
FIGURE 4. The amino acids upstream of the YXXL are required for CLEC-2
signaling.DT40 cells (A) were transfectedwith the stated CLEC-2mutants (B)
and the NFAT-luciferase reporter gene. Transfected cells were stimulated
with 50 nM rhodocytin for 6 h at 37 °C after which time luciferase activity was
measured as a readout of signaling. Results were normalized to -fold increase
over the basal response. Error bars represent themeans S.E. of at least three
separate experiments.
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DISCUSSION
The present study was designed to further dissect the proxi-
mal events in the CLEC-2 signaling pathway which signals
through a single YXXL sequence downstream of an acidic
amino acid region. This work has shown the following: (i)
CLEC-2 can signal through Syk but not Zap-70; (ii) the
upstream triacidic amino acid sequence regulates hemITAM
phosphorylation but is not required for binding to either of the
Syk SH2 domains; (iii) Src-dependent phosphorylation of Syk
precedes phosphorylation of the hemITAM sequence; and (iv)
Syk is the likelymediator of hemITAMphosphorylation. These
results provide further evidence that the proximal events in
hemITAM signaling are distinct from those in ITAM signaling
with a critical difference being that Syk mediates hemITAM
phosphorylation following activation by a Src kinase-depen-
dent pathway that leads to activation of Syk. In contrast, ITAM
FIGURE 5. Surface plasmon resonance measurements of the interaction of Syk with CLEC-2 mutants. Biotinylated CLEC-2 peptides (D) were bound to
streptavidin-coated biosensor chips surfaces. The N-SH2 (A), C-SH2 (B), or the tSH2 domains (C) of Syk were expressed as recombinant protein, purified, and
flowed over the chip at a range of concentrations (0–250 M). Nonlinear curve fitting was used to derive KD values.
FIGURE6.TheDEDsequence is required forCLEC-2signalingandphosphorylation.AandC, DT40cells (A)were transfectedwith the statedCLEC-2mutants
(C) and the NFAT-luciferase reporter gene. Transfected cells were stimulated with 50 nM rhodocytin for 6 h at 37 °C after which time luciferase activity was
measured as a readout of signaling. Results were normalized to -fold increase over the basal response. Error bars represent themeans S.E. of three separate
experiments. B and C, DT40 cells (B) were transfectedwith the stated CLEC-2mutants (C). Transfected cells were stimulatedwith 50 nM rhodocytin for 5min at
37 °C followed by lysis. CLEC-2 was immunoprecipitated (IP), and the proteins were separated by SDS-PAGE and Western blotted (WB) for phosphotyrosine.
Membranes were then reprobed with the immunoprecipitated antibody to measure equal loading. Error bar is means S.E. of two separate experiments.
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receptors are proposed to signal through the sequential activa-
tion of Src and Syk family kinases with phosphorylation of the
ITAM preceding recruitment and activation of Syk or Zap-70,
although there is still debate over whether ITAM phosphory-
lation is entirely Src kinase-dependent (see below).
A critical role for Syk in mediating hemITAM phosphoryla-
tion is consistent with two recent studies using a different Syk
inhibitor, R406, which has a reduced selectivity for Syk over Src
kinases (12), and mutant mice deficient in Src and Syk kinases
(13). In both of these studies, and in the present paper, evidence
is presented that Syk mediates phosphorylation of the CLEC-2
hemITAM. The present study, however, also shows that Syk is
phosphorylated prior to phosphorylation of CLEC-2 by a Src
kinase-dependent pathway. Thus, although the proximal
events in hemITAM and ITAM signaling are distinct, both sets
of receptors signal through the recruitment/activation of one or
more Src kinases, and this is essential for subsequent receptor
phosphorylation. It is interesting to note that the previous study
inmouse platelets (13) showed thatCLEC-2 phosphorylation in
response to rhodocytin but not to a CLEC-2-specific monoclo-
nal antibody was not blocked by Src kinase inhibition, which
contrasts with the present results seen in human platelets. This
suggests that there is a difference between species and ligands
in the relative contribution of Src kinases to Syk activity, which
may be a function of receptor density or agonist-induced cross-
linking or a functional difference in Src or Syk kinase activity.
A key question is themolecular basis of the differential role of
Src andSyk tyrosinekinases inhemITAMand ITAMphosphor-
ylation. In this context it should be emphasized that although
there is strong evidence that phosphorylation of the first tyro-
sine in an ITAM is mediated by a Src kinase, there is evidence
that for some ITAM receptors, the second may be phosphoryl-
ation by a Syk kinases (33). The interplay of these kinases is
therefore governed by their relative levels and localization
within a cell (34, 35). It is likely that differences in kinase levels
and localization and the differences in clustering of the recep-
tors explains why Syk phosphorylation is reduced in the pres-
ence of PRT318 downstream of CLEC-2 but not following acti-
vation of the two ITAM receptors, GPVI-FcR-chain and
FcRIIA. The reduction in Syk phosphorylation observed in the
presenceofPRT318couldbedueeither to lossofautophosphor-
ylation or to the feedback role of secondary agonists and actin
polymerization in CLEC-2 signaling (10).
A further key question is the mechanism through which
receptor dimerization regulates Src- or Syk-dependent phos-
phorylation of hemITAM and ITAM receptors. One explana-
tion is that the kinases are constitutively associated with the
nonphosphorylated ITAM/hemITAM sequence in a resting
cell and that receptor ligation enables the kinases tomediate cis
phosphorylation of an adjacent ITAM/hemITAM. An example
of this is the constitutive association of Src and Syk kinases with
the resting B cell receptor (35, 36). In the case of a hemITAM
receptor, it may be optimal for the Src kinase to phosphorylate
Syk rather than an adjacent hemITAM sequence, and this in
turn mediates phosphorylation of the hemITAM. Either of the
SH2 domains of Syk could then bind with high affinity to the
FIGURE 7. The DED sequence confers hemITAM signaling to an ITAM.DT40 cells (A) were transfected with CLEC-2 or the stated CLEC-2/FcR chimeras ((B)
FcR sequence is underlined) and the NFAT-luciferase reporter gene. Transfected cells were stimulated with 50 nM rhodocytin for 6 h at 37 °C after which time
luciferase activity wasmeasured as a readout of signaling. Results were normalized to -fold increase over the basal response. Error bars represent themeans
S.E. of at least three separate experiments.
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phosphorylated hemITAM, allowing phosphorylation of the
other hemITAM in the dimeric receptor and binding of the
second SH2 domain, thereby leading to Syk activation.
The present study has shown that, in contrast tomany ITAM
receptors, CLEC-2 is unable to signal through the secondmem-
ber of the Syk family of tyrosine kinases, Zap-70. This may
reflect the structural differences in the two kinases in that the
N-SH2 domain in Zap-70, but not the equivalent in Syk,
requires part of the C-SH2 domain for the formation of the
phosphotyrosine binding pocket (37). Thus, Zap-70 may be
conformationally constrained from interacting with two phos-
phorylated hemITAMcytosolic chains. Alternatively, themuch
lower intrinsic kinase activity of Zap-70may prevent significant
hemITAMphosphorylation. The kinase activity of Syk has been
estimated to be	100 times that of Zap-70 (38), although other
studies have shown the difference to be as modest as 3–4-fold
(30). The inability of Zap-70 to reconstitute signaling by
CLEC-2 is consistent with a recent study that was published
during the writing of the present study which describes a novel
mutant mouse in which Zap-70 has been knocked into the Syk
locus. Platelets from the Zap-70-transgenic mouse are unable
to signal in response to activation of CLEC-2 receptor agonists
(39). However, the authors also reported that the platelets did
not respond to GPVI activation, which may reflect the low
intrinsic kinase activity of Zap-70, especially when considered
in light of the rapid activation of platelets that occurs following
activation of the collagen receptor. Therefore, the cell type as
well as the nature of the signalingmotif governs the interplay of
Src and Syk family kinases.
The present study has further emphasized the significance of
the triacidic amino acid sequence that lies upstream of the con-
served YXXL in CLEC-2. The results show that this sequence is
required for phosphorylation of the conserved tyrosine by Syk
but does not mediate binding to the SH2 domains of Syk, as
mutation of this region has a negligible orminor inhibitory role
on the binding of phosphorylated peptides to the N- and C-ter-
minal SH2 domains of Syk. These observations are also unlikely
to be due to an effect of the mutations on ligand binding and
receptor dimerization, as it has been shown previously that
CLEC-2 monomers can bind to rhodocytin on their own (40),
and the model suggests that rhodocytin binding has stabilizing
effects on dimerization. Therefore, the loss in signal of the
mutants is most likely due to the lack of phosphorylation.
The molecular explanation for the loss of phosphorylation is
unclear. The hemITAM sequence is not optimal for phosphor-
ylation by either Syk or Src (Src, Fyn, Lyn, or Blk) (41, 42). We
propose that phosphorylation of the hemITAM is facilitated by
the preceding triacidic amino acid sequence. In support of this,
we show that the introduction of a triacidic amino acid
sequence upstream of one of the two YXXL sequences in the
FcR-chain ITAM (and mutation of the other conserved tyro-
sine to phenylalanine) is sufficient to restore signaling. The lack
of phosphorylation could also be a consequence of altered local-
ization in the surface membrane such that phosphorylation by
Syk is not possible. In particular, triacidic amino acids would be
repelled by the surface membrane, and so this may place the
hemITAM in the vicinity of Syk.
In conclusion, the present study provides further evidence
for key differences in the proximal events in signaling by the
hemITAM receptor CLEC-2 relative to those of ITAM recep-
tors with a critical role for a triacidic amino acid sequence in
supporting phosphorylation by Syk but not Zap-70.
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